So we did this pooled meta-analysis of the factor XI studies in secondary stroke prevention that have been completed to date with the OCEANIC-STROKE of course being the biggest one. But we’re happy to see that there was a consistent effect size in the risk reduction of stroke and no increase in hemorrhages including major hemorrhages but even minor hemorrhages. So those agents hopefully we’re going to change our stroke prevention strategies and they’re going to give us a new tool to reduce the risk of stroke recurrence without increasing the hemorrhagic risk of patients after a stroke...
So we did this pooled meta-analysis of the factor XI studies in secondary stroke prevention that have been completed to date with the OCEANIC-STROKE of course being the biggest one. But we’re happy to see that there was a consistent effect size in the risk reduction of stroke and no increase in hemorrhages including major hemorrhages but even minor hemorrhages. So those agents hopefully we’re going to change our stroke prevention strategies and they’re going to give us a new tool to reduce the risk of stroke recurrence without increasing the hemorrhagic risk of patients after a stroke.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.